XM does not provide services to residents of the United States of America.

Technical Analysis – EURJPY uncovers upside forces as it recoils to 100-MA



EURJPY has managed to unearth some bullish forces around the 100-day simple moving average (SMA) at 130.56, currently merging with the Ichimoku cloud’s lower boundary. The pair has succeeded in countering the strong fading of the pair from the near 40-month region of highs, which ticked down to the 130.00 handle. Nonetheless, the advancing SMAs are providing bullish defences for the broader uptrend.

The Ichimoku lines are reflecting that downside pressure is subsiding, while the short-term oscillators are demonstrating mixed signals in directional momentum. The MACD has plunged below zero and has distanced itself far beneath its red trigger line, while the RSI is improving after its bounce off of the 30 level. The stochastic oscillator is promoting bullish traction off strong footing, formed at the lower frontier of the Ichimoku cloud.

Returning above the cloud, initial upside constraints could emanate from the resistance zone of 132.17-132.77. That said, hiking above this obstacle could encourage buyers to challenge the resistance ceiling of 133.57-134.16, which also includes the multi-year high of 134.12 and the 134.16 barrier, identified in February 2018. Breaching the peak could then steer the bulls towards the 134.83 border, formed back in early February 2018.

Otherwise, for the downward trajectory to persist, sellers would need to pierce beneath the immediate support section of 130.56-131.00. Should this base give way, the previous candle’s low at 130.00 and the 129.56 level could try to impede the decline from gaining pace and testing the critical trough of 128.28, from March 24.

Summarizing, EURJPY’s near-term positive tone should remain intact if the price persists above the 100-day SMA and the 129.56 barrier. Moreover, a return in the price to the vicinity of 133.00 could bolster optimism.

 

 

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.